Savara (SVRA) Amortizatization of Intangibles (2012 - 2026)

Savara (SVRA) reported Amortizatization of Intangibles of $42000.0 for Q1 2026, down 96.34% year-over-year from $1.1 million in Q1 2025, and down 98.47% on a QoQ basis from $2.7 million in Q4 2025.

Savara (SVRA) has 9 years of Amortizatization of Intangibles data on file, last reported at $42000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 96.34% year-over-year to $42000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 66.31% YoY) and the FY2025 annual result came in at $2.9 million, down 47.34% from the prior year.
  • Amortizatization of Intangibles slipped to $42000.0 in Q1 2026 per SVRA's latest filing, from $2.7 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $5.3 million in Q4 2024 and bottomed at -$1.3 million in Q2 2024.
  • The 5-year median for Amortizatization of Intangibles is $42000.0 (2026), against an average of $779941.2.
  • The widest annual swing landed in 2022, when Amortizatization of Intangibles slumped 568.42%; it then surged 9033.33% in 2024.
  • Tracing SVRA's Amortizatization of Intangibles over 5 years: stood at $357000.0 in 2022, then soared by 359.1% to $1.6 million in 2023, then jumped by 225.5% to $5.3 million in 2024, then sank by 48.49% to $2.7 million in 2025, then slumped by 98.47% to $42000.0 in 2026.
  • Per Business Quant, the three latest SVRA Amortizatization of Intangibles figures stand at $42000.0 (Q1 2026), $2.7 million (Q4 2025), and $40000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 13,267.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Savara 1.30 Bn 1.30 Bn - 42,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 42,000.00
Mar 31, 2026 42,000.00
Dec 31, 2025 2.75 Mn
Dec 31, 2025 2.75 Mn
Sep 30, 2025 40,000.00
Sep 30, 2025 40,000.00
Jun 30, 2025 -1.07 Mn
Jun 30, 2025 -1.07 Mn
Mar 31, 2025 1.15 Mn
Mar 31, 2025 1.15 Mn
Dec 31, 2024 5.34 Mn
Dec 31, 2024 5.34 Mn
Sep 30, 2024 36,000.00
Sep 30, 2024 36,000.00
Jun 30, 2024 -1.30 Mn
Jun 30, 2024 -1.30 Mn
Mar 31, 2024 1.37 Mn
Mar 31, 2024 1.37 Mn
Dec 31, 2023 1.64 Mn
Dec 31, 2023 1.64 Mn
Sep 30, 2023 1.51 Mn
Sep 30, 2023 1.51 Mn
Jun 30, 2023 1.82 Mn
Jun 30, 2023 1.82 Mn
Mar 31, 2023 15,000.00
Mar 31, 2023 15,000.00
Dec 31, 2022 357,000.00
Dec 31, 2022 357,000.00
Sep 30, 2022 -61,000.00
Sep 30, 2022 -61,000.00
Jun 30, 2022 -104,000.00
Jun 30, 2022 -104,000.00
Mar 31, 2022 -267,000.00
Mar 31, 2022 -267,000.00
Dec 31, 2021 135,000.00
Dec 31, 2021 135,000.00
Sep 30, 2021 764,000.00
Sep 30, 2021 764,000.00
Jun 30, 2021 -725,000.00
Jun 30, 2021 -725,000.00
Mar 31, 2021 57,000.00
Mar 31, 2021 57,000.00
Dec 31, 2020 348,000.00
Dec 31, 2020 348,000.00
Sep 30, 2020 -23,000.00
Sep 30, 2020 -23,000.00
Jun 30, 2020 44,000.00
Jun 30, 2020 44,000.00
Mar 31, 2020 69,000.00
Mar 31, 2020 69,000.00
Dec 31, 2019 180,000.00
Dec 31, 2019 180,000.00
Sep 30, 2012 -2,957.00
Sep 30, 2012 -2,957.00
Jun 30, 2012 -8,173.00
Jun 30, 2012 -8,173.00
Mar 31, 2012 -10,710.00
Mar 31, 2012 -10,710.00